The role of neutrophils and NETosis in autoimmune and renal diseases

Nature Reviews Nephrology

Volumn 12, Issue 7, 2016, Pages 402-413

  Gupta, Sarthak ^a   Kaplan, Mariana J ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANCA ASSOCIATED VASCULITIS; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; CELL FUNCTION; DRUG TARGETING; EXTRACELLULAR TRAP; EXTRACELLULAR TRAP CLEARANCE; EXTRACELLULAR TRAP FORMATION; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY INJURY; NEPHRITIS; NEUTROPHIL; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; AUTOIMMUNE DISEASES; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; PHYSIOLOGY;

ANIMALS; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; AUTOIMMUNE DISEASES; EXTRACELLULAR TRAPS; HUMANS; KIDNEY DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEUTROPHILS;

EID: 84973154725     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2016.71     Document Type: Review

References (163)

1. Nauseef, W. M., & Borregaard, N. Neutrophils at work. Nat. Immunol. 15, 602-611 (2014
2. Bardoel, B. W., Kenny, E. F., Sollberger, G., & Zychlinsky, A. The balancing act of neutrophils. Cell Host Microbe 15, 526-536 (2014
3. Brinkmann, V., et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532-1535 (2004
4. Keshari, R. S., et al. Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition. PLoS ONE 7, e48111 (2012
5. Schorn, C., et al. Monosodium urate crystals induce extracellular DNA traps in neutrophils, eosinophils, and basophils but not in mononuclear cells. Front. Immunol. 3, 277 (2012
6. Yalavarthi, S., et al. Antiphospholipid antibodies promote the release of neutrophil extracellular traps: a new mechanism of thrombosis in the antiphospholipid syndrome. Arthritis Rheumatol. 67, 2990-3003 (2015
7. Behnen, M., et al. Immobilized immune complexes induce neutrophil extracellular trap release by human neutrophil granulocytes via FcγRIIIB and Mac 1. J. Immunol. 193, 1954-1965 (2014
8. Mantovani, A., Cassatella, M. A., Costantini, C., & Jaillon, S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11, 519-531 (2011
9. Scapini, P., Bazzoni, F., & Cassatella, M. A. Regulation of B cell-activating factor (BAFF)/B lymphocyte stimulator (BLyS) expression in human neutrophils. Immunol. Lett. 116, 1-6 (2008
10. Huard, B., et al. APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa. J. Clin. Invest. 118, 2887-2895 (2008
11. Tvinnereim, A. R., Hamilton, S. E., & Harty, J. T. Neutrophil involvement in cross-priming CD8+ T cell responses to bacterial antigens. J. Immunol. 173, 1994-2002 (2004
12. Fazio, J., Kalyan, S., Wesch, D., & Kabelitz, D. Inhibition of human γd T cell proliferation and effector functions by neutrophil serine proteases. Scand. J. Immunol. 80, 381-389 (2014
13. Megiovanni, A. M., et al. Polymorphonuclear neutrophils deliver activation signals and antigenic molecules to dendritic cells: a new link between leukocytes upstream of T lymphocytes. J. Leukoc. Biol. 79, 977-988 (2006
14. Yang, C. W., Strong, B. S., Miller, M. J., & Unanue, E. R. Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants. J. Immunol. 185, 2927-2934 (2010
15. Garcia-Romo, G. S., et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra20 (2011
16. Semeraro, F., et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood 118, 1952-1961 (2011
17. Rahman, A., & Isenberg, D. A. Systemic lupus erythematosus. N. Engl. J. Med. 358, 929-939 (2008
18. Jennette, J. C., et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 65, 1-11 (2013
19. McInnes, I. B., & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205-2219 (2011
20. Giannakopoulos, B., & Krilis, S. A. The pathogenesis of the antiphospholipid syndrome. N. Engl. J. Med. 368, 1033-1044 (2013
21. Kolaczkowska, E., & Kubes, P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13, 159-175 (2013
22. Pillay, J., et al. In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood 116, 625-627 (2010
23. Summers, C., et al. Neutrophil kinetics in health and disease. Trends Immunol. 31, 318-324 (2010
24. Colotta, F., Re, F., Polentarutti, N., Sozzani, S., & Mantovani, A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80, 2012-2020 (1992
25. Herter, J., & Zarbock, A. Integrin regulation during leukocyte recruitment. J. Immunol. 190, 4451-4457 (2013
26. Henson, P. M. Pathologic mechanisms in neutrophil-mediated injury. Am. J. Pathol. 68, 593-612 (1972
27. Borregaard, N., & Cowland, J. B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89, 3503-3521 (1997
28. Lominadze, G., et al. Proteomic analysis of human neutrophil granules. Mol. Cell. Proteomics 4, 1503-1521 (2005
29. Faurschou, M., & Borregaard, N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5, 1317-1327 (2003
30. Kobayashi, S. D., & DeLeo, F. R. Role of neutrophils in innate immunity: a systems biology-level approach. Wiley Interdiscip. Rev. Syst. Biol. Med. 1, 309-333 (2009
31. Fossati, G., et al. The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis. J. Immunol. 170, 1964-1972 (2003
32. Fransen, M., Nordgren, M., Wang, B., & Apanasets, O. Role of peroxisomes in ROS/RNS-metabolism: implications for human disease. Biochim. Biophys. Acta 1822, 1363-1373 (2012
33. Rodriguez, P. C., et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T cell receptor expression and antigen-specific T cell responses. Cancer Res. 64, 5839-5849 (2004
34. Bowers, N. L., et al. Immune suppression by neutrophils in HIV 1 infection: role of PD L1/PD 1 pathway. PLoS Pathog. 10, e1003993 (2014
35. Puga, I., et al. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat. Immunol. 13, 170-180 (2012
36. Lande, R., et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra19 (2011
37. Tillack, K., Breiden, P., Martin, R., & Sospedra, M. T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses. J. Immunol. 188, 3150-3159 (2012
38. Fuchs, T. A., et al. Extracellular DNA traps promote thrombosis. Proc. Natl Acad. Sci. USA 107, 15880-15885 (2010
39. Massberg, S., et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat. Med. 16, 887-896 (2010
40. Clark, S. R., et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13, 463-469 (2007
41. von Bruhl, M. L., et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J. Exp. Med. 209, 819-835 (2012
42. Barrientos, L., et al. Neutrophil extracellular traps downregulate lipopolysaccharide-induced activation of monocyte-derived dendritic cells. J. Immunol. 193, 5689-5698 (2014
43. Schauer, C., et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat. Med. 20, 511-517 (2014
44. Fuchs, T. A., et al. Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176, 231-241 (2007
45. Pilsczek, F. H., et al. A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J. Immunol. 185, 7413-7425 (2010
46. Buchanan, J. T., et al. DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr. Biol. 16, 396-400 (2006
47. Ramos-Kichik, V., et al. Neutrophil extracellular traps are induced by Mycobacterium tuberculosis. Tuberculosis (Edinb.) 89, 29-37 (2009
48. Bruns, S., et al. Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA. PLoS Pathog. 6, e1000873 (2010
49. Abi Abdallah, D. S., et al. Toxoplasma gondii triggers release of human and mouse neutrophil extracellular traps. Infect. Immun. 80, 768-777 (2012
50. Saitoh, T., et al. Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus 1. Cell Host Microbe 12, 109-116 (2012
51. Gupta, A. K., Giaglis, S., Hasler, P., & Hahn, S. Efficient neutrophil extracellular trap induction requires mobilization of both intracellular and extracellular calcium pools and is modulated by cyclosporine A. PLoS ONE 9, e97088 (2014
52. Metzler, K. D., Goosmann, C., Lubojemska, A., Zychlinsky, A., & Papayannopoulos, V. A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis. Cell Rep. 8, 883-896 (2014
53. Palmer, L. J., et al. Hypochlorous acid regulates neutrophil extracellular trap release in humans. Clin. Exp. Immunol. 167, 261-268 (2012
54. Tessarz, P., & Kouzarides, T. Histone core modifications regulating nucleosome structure and dynamics. Nat. Rev. Mol. Cell Biol. 15, 703-708 (2014
55. Yipp, B. G., et al. Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat. Med. 18, 1386-1393 (2012
56. Yousefi, S., Mihalache, C., Kozlowski, E., Schmid, I., & Simon, H. U. Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ. 16, 1438-1444 (2009
57. Hakkim, A., et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl Acad. Sci. USA 107, 9813-9818 (2010
58. Farrera, C., & Fadeel, B. Macrophage clearance of neutrophil extracellular traps is a silent process. J. Immunol. 191, 2647-2656 (2013
59. Canas, C. A., Canas, F., Bonilla-Abadia, F., Ospina, F. E., & Tobon, G. J. Epigenetics changes associated to environmental triggers in autoimmunity. Autoimmunity 49, 1-11 (2016
60. Davidson, A., & Diamond, B. Autoimmune diseases. N. Engl. J. Med. 345, 340-350 (2001
61. Cocca, B. A., Cline, A. M., & Radic, M. Z. Blebs and apoptotic bodies are B cell autoantigens. J. Immunol. 169, 159-166 (2002
62. Tait, S. W., Ichim, G., & Green, D. R. Die another way - non-apoptotic mechanisms of cell death. J. Cell Sci. 127, 2135-2144 (2014
63. Gehrke, N., et al. Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing. Immunity 39, 482-495 (2013
64. Abou-Raya, A., & Abou-Raya, S. Inflammation: a pivotal link between autoimmune diseases and atherosclerosis. Autoimmun. Rev. 5, 331-337 (2006
65. Tektonidou, M. G., Laskari, K., Panagiotakos, D. B., & Moutsopoulos, H. M. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum. 61, 29-36 (2009
66. Merkel, P. A., et al. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener?s Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann. Intern. Med. 142, 620-626 (2005
67. Sokolove, J., et al. Brief report: citrullination within the atherosclerotic plaque: a potential target for the anti-citrullinated protein antibody response in rheumatoid arthritis. Arthritis Rheum. 65, 1719-1724 (2013
68. Smith, C. K., et al. Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus. Arthritis Rheumatol. 66, 2532-2544 (2014
69. Kambas, K., Mitroulis, I., & Ritis, K. The emerging role of neutrophils in thrombosis - the journey of TF through NETs. Front. Immunol. 3, 385 (2012
70. Mayadas, T. N., Rosetti, F., Ernandez, T., & Sethi, S. Neutrophils: game changers in glomerulonephritis? Trends Mol. Med. 16, 368-378 (2010
71. Crow, M. K. Type I interferon in the pathogenesis of lupus. J. Immunol. 192, 5459-5468 (2014
72. Hacbarth, E., & Kajdacsy-Balla, A. Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever. Arthritis Rheum. 29, 1334-1342 (1986
73. Denny, M. F., et al. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J. Immunol. 184, 3284-3297 (2010
74. Bennett, L., et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 197, 711-723 (2003
75. Villanueva, E., et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J. Immunol. 187, 538-552 (2011
76. Leffler, J., et al. Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J. Immunol. 188, 3522-3531 (2012
77. Carmona-Rivera, C., Zhao, W., Yalavarthi, S., & Kaplan, M. J. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase 2. Ann. Rheum. Dis. 74, 1417-1424 (2015
78. Lood, C., et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat. Med. 22, 146-153 (2016
79. Kahlenberg, J. M., Carmona-Rivera, C., Smith, C. K., & Kaplan, M. J. Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J. Immunol. 190, 1217-1226 (2013
80. Knight, J. S., et al. Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis. Circ. Res. 114, 947-956 (2014
81. Knight, J. S., et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Ann. Rheum. Dis. 74, 2199-2206 (2015
82. Knight, J. S., et al. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J. Clin. Invest. 123, 2981-2993 (2013
83. Campbell, A. M., Kashgarian, M., & Shlomchik, M. J. NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus. Sci. Transl. Med. 5, 157ra141 (2012
84. Winkelstein, J. A., et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79, 155-169 (2000
85. Falk, R. J., & Jennette, J. C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N. Engl. J. Med. 318, 1651-1657 (1988
86. Niles, J. L., McCluskey, R. T., Ahmad, M. F., & Arnaout, M. A. Wegener?s granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 74, 1888-1893 (1989
87. Jennette, J. C., & Falk, R. J. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat. Rev. Rheumatol. 10, 463-473 (2014
88. Charles, L. A., Caldas, M. L., Falk, R. J., Terrell, R. S., & Jennette, J. C. Antibodies against granule proteins activate neutrophils in vitro. J. Leukoc. Biol. 50, 539-546 (1991
89. Falk, R. J., Terrell, R. S., Charles, L. A., & Jennette, J. C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc. Natl Acad. Sci. USA 87, 4115-4119 (1990
90. Freeley, S. J., Coughlan, A. M., Popat, R. J., Dunn-Walters, D. K., & Robson, M. G. Granulocyte colony stimulating factor exacerbates antineutrophil cytoplasmic antibody vasculitis. Ann. Rheum. Dis. 72, 1053-1058 (2013
91. Huugen, D., et al. Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-α. Am. J. Pathol. 167, 47-58 (2005
92. Schreiber, A., et al. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J. Am. Soc. Nephrol. 20, 289-298 (2009
93. Wang, H., Wang, C., Zhao, M. H., & Chen, M. Neutrophil extracellular traps can activate alternative complement pathways. Clin. Exp. Immunol. 181, 518-527 (2015
94. Kambas, K., et al. Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease. Ann. Rheum. Dis. 73, 1854-1863 (2014
95. Huang, Y. M., Wang, H., Wang, C., Chen, M., & Zhao, M. H. C5a inducing tissue factor expressing microparticles and neutrophil extracellular traps promote hypercoagulability in ANCA-associated vasculitis. Arthritis Rheumatol. 67, 2780-2790 (2015
96. Kessenbrock, K., et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15, 623-625 (2009
97. Tang, S., et al. Neutrophil extracellular trap formation is associated with autophagy-related signalling in ANCA-associated vasculitis. Clin. Exp. Immunol. 180, 408-418 (2015
98. Pepper, R. J., et al. Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis. Kidney Int. 83, 1150-1158 (2013
99. Soderberg, D., et al. Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission. Rheumatology 54, 2085-2094 (2015
100. Yoshida, M., Sasaki, M., Sugisaki, K., Yamaguchi, Y., & Yamada, M. Neutrophil extracellular trap components in fibrinoid necrosis of the kidney with myeloperoxidase-ANCA-associated vasculitis. Clin. Kidney J. 6, 308-312 (2013
101. Nakazawa, D., et al. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 64, 3779-3787 (2012
102. Sangaletti, S., et al. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. Blood 120, 3007-3018 (2012
103. Nakazawa, D., et al. Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated microscopic polyangiitis. J. Am. Soc. Nephrol. 25, 990-997 (2014
104. Vinicki, J. P., et al. Analysis of 65 renal biopsies from patients with rheumatoid arthritis: change in treatment strategies decreased frequency and modified histopathological findings. J. Clin. Rheumatol. 21, 335-340 (2015
105. Makrygiannakis, D., et al. Citrullination is an inflammation-dependent process. Ann. Rheum. Dis. 65, 1219-1222 (2006
106. Kidd, B. A., et al. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res. Ther. 10, R119 (2008
107. Khandpur, R., et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci. Transl. Med. 5, 178ra140 (2013
108. van Beers, J. J., et al. The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and β-actin. Arthritis Rheum. 65, 69-80 (2013
109. Spengler, J., et al. Release of active peptidyl arginine deiminases by neutrophils can explain production of extracellular citrullinated autoantigens in rheumatoid arthritis synovial fluid. Arthritis Rheumatol. 67, 3135-3145 (2015
110. Jones, J. E., Causey, C. P., Knuckley, B., Slack-Noyes, J. L., & Thompson, P. R. Protein arginine deiminase 4 (PAD4): current understanding and future therapeutic potential. Curr. Opin. Drug Discov. Devel. 12, 616-627 (2009
111. Foulquier, C., et al. Peptidyl arginine deiminase type 2 (PAD 2) and PAD 4 but not PAD 1, PAD 3, and PAD 6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum. 56, 3541-3553 (2007
112. Pratesi, F., et al. Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps. Ann. Rheum. Dis. 73, 1414-1422 (2014
113. Miyakis, S., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4, 295-306 (2006
114. Sciascia, S., Cuadrado, M. J., Khamashta, M., & Roccatello, D. Renal involvement in antiphospholipid syndrome. Nat. Rev. Nephrol. 10, 279-289 (2014
115. Brill, A., et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J. Thromb. Haemost. 10, 136-144 (2012
116. Leffler, J., et al. Degradation of neutrophil extracellular traps is decreased in patients with antiphospholipid syndrome. Clin. Exp. Rheumatol. 32, 66-70 (2014
117. Van Den Hoogen, L. L., et al. Low-density granulocytes are increased in antiphospholipid syndrome and are associated with anti-β2-glycoprotein I antibodies: comment on the article by Yalavarthi, et al. Arthritis Rheumatol. http://dx.doi.org/10.1002/art.39576 (2016
118. Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. Type 1 diabetes. Lancet 383, 69-82 (2014
119. Bjornstad, P., Cherney, D., & Maahs, D. M. Early diabetic nephropathy in type 1 diabetes: new insights. Curr. Opin. Endocrinol. Diabetes Obes. 21, 279-286 (2014
120. Diana, J., et al. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat. Med. 19, 65-73 (2013
121. Valle, A., et al. Reduction of circulating neutrophils precedes and accompanies type 1 diabetes. Diabetes 62, 2072-2077 (2013
122. Harsunen, M. H., et al. Reduced blood leukocyte and neutrophil numbers in the pathogenesis of type 1 diabetes. Horm. Metab. Res. 45, 467-470 (2013
123. Wang, Y., et al. Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with β-cell autoimmunity in patients with type 1 diabetes. Diabetes 63, 4239-4248 (2014
124. Wong, S. L., et al. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat. Med. 21, 815-819 (2015
125. Fadini, G. P., et al. NETosis delays diabetic wound healing in mice and humans. Diabetes http://dx.doi. org/10.2337/db15-0863 (2016
126. Hricik, D. E., Chung-Park, M., & Sedor, J. R. Glomerulonephritis. N. Engl. J. Med. 339, 888-899 (1998
127. O'Sullivan, K. M., et al. Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis. Kidney Int. 88, 1030-1046 (2015
128. Leffler, J., et al. Degradation of neutrophil extracellular traps co varies with disease activity in patients with systemic lupus erythematosus. Arthritis Res. Ther. 15, R84 (2013
129. Schreiber, A., et al. Neutrophil serine proteases promote IL 1β generation and injury in necrotizing crescentic glomerulonephritis. J. Am. Soc. Nephrol. 23, 470-482 (2012
130. Kanzaki, G., et al. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis. Nephrol. Dial. Transplant. 31, 574-585 (2016
131. Pisitkun, P., et al. Interleukin 17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity 37, 1104-1115 (2012
132. Disteldorf, E. M., et al. CXCL5 drives neutrophil recruitment in TH17 mediated GN. J. Am. Soc. Nephrol. 26, 55-66 (2015
133. Odobasic, D., Kitching, A. R., Semple, T. J., & Holdsworth, S. R. Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis. J. Am. Soc. Nephrol. 18, 760-770 (2007
134. Odobasic, D., et al. Suppression of autoimmunity and renal disease in pristane-induced lupus by myeloperoxidase. Arthritis Rheumatol. 67, 1868-1880 (2015
135. Brennan, M. L., et al. Increased atherosclerosis in myeloperoxidase-deficient mice. J. Clin. Invest. 107, 419-430 (2001
136. Mangold, A., et al. Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST elevation acute coronary syndrome are predictors of ST segment resolution and infarct size. Circ. Res. 116, 1182-1192 (2015
137. Hirahashi, J., et al. Mac 1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury. Circulation 120, 1255-1265 (2009
138. Ooi, J. D., et al. FcγRIIB regulates T cell autoreactivity, ANCA production, and neutrophil activation to suppress anti-myeloperoxidase glomerulonephritis. Kidney Int. 86, 1140-1149 (2014
139. Tsuboi, N., Asano, K., Lauterbach, M., & Mayadas, T. N. Human neutrophil Fcγ receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases. Immunity 28, 833-846 (2008
140. Remijsen, Q., et al. Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res. 21, 290-304 (2011
141. Patel, S., et al. Nitric oxide donors release extracellular traps from human neutrophils by augmenting free radical generation. Nitric Oxide 22, 226-234 (2010
142. Garcia, R. J., et al. Attention deficit and hyperactivity disorder scores are elevated and respond to N acetylcysteine treatment in patients with systemic lupus erythematosus. Arthritis Rheum. 65, 1313-1318 (2013
143. Lai, Z. W., et al. N acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 64, 2937-2946 (2012
144. Zheng, W., et al. PF 1355, a mechanism-based myeloperoxidase inhibitor, prevents immune complex vasculitis and anti-glomerular basement membrane glomerulonephritis. J. Pharmacol. Exp. Ther. 353, 288-298 (2015
145. Willis, V. C., et al. N α-benzoyl N5-(2 chloro 1 iminoethyl)-l ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J. Immunol. 186, 4396-4404 (2011
146. Martinod, K., et al. PAD4 deficiency does not affect bacteremia in polymicrobial sepsis and ameliorates endotoxemic shock. Blood 125, 1948-1956 (2015
147. Li, P., et al. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J. Exp. Med. 207, 1853-1862 (2010
148. Sulem, P., et al. Identification of a large set of rare complete human knockouts. Nat. Genet. 47, 448-452 (2015
149. Sorensen, O. E., et al. Papillon-Lèfevre syndrome patient reveals species-dependent requirements for neutrophil defenses. J. Clin. Invest. 124, 4539-4548 (2014
150. Cohen, S. B., et al. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum. 54, 2793-2806 (2006
151. Stone, J. H., et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N. Engl. J. Med. 363, 221-232 (2010
152. Zavada, J., et al. Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study. Lupus 19, 1281-1289 (2010
153. Lee, Y. H., Lee, H. S., Choi, S. J., Dai Ji, J., & Song, G. G. Efficacy and safety of tacrolimus therapy for lupus nephritis: a systematic review of clinical trials. Lupus 20, 636-640 (2011
154. Cedervall, J., et al. Neutrophil extracellular traps accumulate in peripheral blood vessels and compromise organ function in tumor-bearing animals. Cancer Res. 75, 2653-2662 (2015
155. Sayah, D. M., et al. Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation. Am. J. Respir. Crit. Care Med. 191, 455-463 (2015
156. Macanovic, M., et al. The treatment of systemic lupus erythematosus (SLE) in NZB/W F1 hybrid mice; studies with recombinant murine DNase and with dexamethasone. Clin. Exp. Immunol. 106, 243-252 (1996
157. Davis, J. C. Jr., et al. Recombinant human Dnase I (rhDNase) in patients with lupus nephritis. Lupus 8, 68-76 (1999
158. Neeli, I., Dwivedi, N., Khan, S., & Radic, M. Regulation of extracellular chromatin release from neutrophils. J. Innate Immun. 1, 194-201 (2009
159. Xu, Z., et al. Interaction of kindlin 3 and β2 integrins differentially regulates neutrophil recruitment and NET release in mice. Blood 126, 373-377 (2015
160. Taylor, P. C., & Feldmann, M. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat. Rev. Rheumatol. 5, 578-582 (2009
161. Kunwar, S., Dahal, K., & Sharma, S. Anti IL 17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials. Rheumatol. Int. http://dx.doi. org/10.1007/s00296-016-3480-9 (2016
162. Wang, Y., et al. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc. Natl Acad. Sci. USA 93, 8563-8568 (1996
163. Furie, R., M. L., Rollins, S. A., & Mojcik, C. F. 64th Annual Scientific Meeting of the American College of Rheumatology (San Francisco, 2001